Tag: Nursing

A 50mCi Tc99 Mebrofenin sample contains 5 uCi Mo99. If a patient is to be injected with 5 mCi for a hepatobiliary study 6 hours later, can you administer this RP to the patient?

26. EMS provider has selected to orally intubate a non-breathing patient with a cuffed intubation tubeWhat is the for choosing endotracheal intubation versus other advanced airways?

Ask an expert
You are asked to make metoclopramide CRI for a patient who is 30 kg. The fluid rate is 100 mL/hr and the dose is 1 mg/kg/day. How many mg/L will you add to the fluids?

How often can Methotrexate (Rheumatrex) for RA be orally administered?Select one:
A. Once weekly as a single dose.
B. Every 12 hours for three doses once weekly.
C. Daily
D. A or B

One of the factors that influence protein allowance during acute renal failure is the individual’s:(CO4)
Blood pressure
Degree of catabolism
Serum albumin concentration
Level of activity

Question 7
Which health model views treating disease through medications and surgery as the surest way to improve health?
environmental model
public health model
social model
medical model

In PPN, carbohydrates are supplied as dextrose monohydrate. Dextrose monohydrate yields _____ calories per gram.
Group of answer choices
2 kcal/gm
1.1 kcal/gm
4 kcal/gm
3.4 kcal/gm

Primary prevention is:
Reduced impact of a current disease or state
Focuses on detection of disease
Actions that keep people from disease and illness initially
Screening for colon cancer

Obesity: Issue Overview and the Roles of Cost, Quality, and Access
Obesity is a growing global public health challenge associated with increased risk of noncommunicable diseases (cardiovascular disease, type 2 diabetes, certain cancers), reduced quality of life, and increased health system burden (WHO, 2023). Prevalence remains high and rising in many regions, with substantial variation by country, socioeconomic status, and population subgroup (CDC, 2023; WHO, 2023).
Scope and consequences
The health and economic consequences of obesity include higher direct medical costs (treatment, medications, procedures), indirect costs (lost productivity, disability), and broader social impacts. The economic burden is large and projected to grow unless prevention and treatment strategies are scaled up (OECD, 2019; WHO, 2023).
Role of Cost
Cost affects both individual-level decisions and system-level provision of obesity prevention and treatment:
Individual affordability: Healthy foods, structured physical activity programs, behavioral interventions, and evidence-based medications or bariatric surgery often incur higher out-of-pocket costs compared with cheaper ultra-processed foods, creating a financial barrier to healthy choices (OECD, 2019).
Health-system financing: Limited public financing for obesity prevention and long-term management can restrict availability of multidisciplinary services (dietitians, behavioral therapy, medications), leading to under-treatment (WHO, 2023).
Macroeconomic impact: Employers and payers face higher healthcare spending and productivity losses associated with obesity, creating incentives for some payers to invest in prevention but barriers remain in translating that into accessible programs for all (OECD, 2019).
Role of Quality
Quality of care determines effectiveness and safety of obesity interventions:
Evidence-based care: Access to high-quality, evidence-based services (behavioral counseling, medical therapy, bariatric surgery when indicated) improves outcomes. Poor-quality or fragmented care reduces effectiveness and may increase harm or wasted resources (Kruk et al., 2018).
Provider training and guidelines: Variability in provider knowledge and adherence to guidelines affects the delivery of appropriate interventions and follow-up, influencing long-term success rates.
Measurement and outcomes: High-quality systems measure outcomes, support continuity of care, and evaluate interventions for equitable effectiveness; low-quality systems fail to do so and perpetuate poor results (Kruk et al., 2018).
Role of Access
Access encompasses availability, geographic proximity, cultural acceptability, and insurance coverage:
Geographic and service availability: Rural and underserved areas often lack multidisciplinary obesity services, limiting access to effective treatments.
Insurance and coverage: Lack of coverage for nutritional counseling, pharmacotherapy, or bariatric surgery creates inequities; where coverage exists, utilization may still be low due to co-pays and prior authorization hurdles (CDC, 2023).
Social determinants: Income, education, food environments, and built environments shape access to healthy options; policies that do not address these upstream determinants leave access barriers unaddressed (WHO, 2023).
Interactions and Impact
Cost, quality, and access interact: high costs and poor coverage limit access; limited access concentrates demand on low-quality or inappropriate services; and low-quality care increases long-term costs through complications and treatment failures. Together these factors perpetuate disparities in obesity prevalence and outcomes across socioeconomic and demographic groups (OECD, 2019; WHO, 2023).
Policy and Programmatic Implications
Increase public investment in prevention (healthy food environments, physical activity infrastructure) to reduce long-term costs and expand equitable access (WHO, 2023).
Expand insurance coverage and reduce financial barriers for evidence-based treatments, including behavioral interventions and effective pharmacotherapies, with attention to cost-effectiveness and equity (OECD, 2019).
Strengthen quality: implement guidelines, provider training, outcome measurement, and integrated care pathways that ensure continuity and high-quality multidisciplinary care (Kruk et al., 2018).
Address upstream social determinants through cross-sector policies (food systems, urban planning, education) so that access to healthy options is affordable and widely available (WHO, 2023).
Conclusions
Addressing obesity effectively requires coordinated actions that reduce cost barriers, improve quality of care, and expand equitable access. Policies that combine prevention, high-quality treatment, and financial protections are most likely to reduce the burden of obesity and its inequities (WHO, 2023; OECD, 2019).
References
World Health Organization (WHO). Obesity and overweight. 2023. Available at:
https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
(accessed 2023).
Centers for Disease Control and Prevention (CDC). Adult Obesity Facts. 2023. Available at:
https://www.cdc.gov/obesity/data/adult.html
(accessed 2023).
Organisation for Economic Co-operation and Development (OECD). The Heavy Burden of Obesity: The Economics of Prevention. OECD, 2019. Available at:
https://www.oecd.org/health/the-heavy-burden-of-obesity-67450d67-en.htm
(accessed 2019).
Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet. 2018;392(10160): 1–14. Available at:
https://www.thelancet.com/commissions/quality-health-systems
(accessed 2018).
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002. Available at:
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
(accessed 2021).

A q, is a healthcare professional employed by a patient or patient’s family to perform nursing care for a patient
certified nursing assiatant
agency nurse
special duty nurse
float nurse